• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于预测肝细胞癌经动脉化疗栓塞反应的计算机断层扫描和磁共振成像的影像组学特征:一项荟萃分析

Radiomics features of computed tomography and magnetic resonance imaging for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis.

作者信息

Feng Lijuan, Chen Qianjuan, Huang Linjie, Long Liling

机构信息

Department of Radiology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Key Laboratory of Early Prevention and Treatment for Regional High Frequency Tumor, Gaungxi Medical University, Ministry of Education, Nanning, Guangxi, China.

出版信息

Front Oncol. 2023 Jul 13;13:1194200. doi: 10.3389/fonc.2023.1194200. eCollection 2023.

DOI:10.3389/fonc.2023.1194200
PMID:37519801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10374837/
Abstract

PURPOSE

To examine the methodological quality of radiomics-related studies and evaluate the ability of radiomics to predict treatment response to transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC).

METHODS

A systematic review was performed on radiomics-related studies published until October 15, 2022, predicting the effectiveness of TACE for HCC. Methodological quality and risk of bias were assessed using the Radiomics Quality Score (RQS) and Quality Assessment of Diagnostic Accuracy Studies-2 tools, respectively. Pooled sensitivity, pooled specificity, and area under the curve (AUC) were determined to evaluate the utility of radiomics in predicting the response to TACE for HCC.

RESULTS

In this systematic review, ten studies were eligible, and six of these studies were used in our meta-analysis. The RQS ranged from 7-21 (maximum possible score: 36). The pooled sensitivity and specificity were 0.89 (95% confidence interval (CI) = 0.79-0.95) and 0.82 (95% CI = 0.64-0.92), respectively. The overall AUC was 0.93 (95% CI = 0.90-0.95).

CONCLUSION

Radiomics-related studies evaluating the efficacy of TACE in patients with HCC revealed promising results. However, prospective and multicenter trials are warranted to make radiomics more feasible and acceptable.

摘要

目的

探讨放射组学相关研究的方法学质量,并评估放射组学预测肝细胞癌(HCC)经动脉化疗栓塞术(TACE)治疗反应的能力。

方法

对截至2022年10月15日发表的预测TACE治疗HCC疗效的放射组学相关研究进行系统评价。分别使用放射组学质量评分(RQS)和诊断准确性研究质量评估-2工具评估方法学质量和偏倚风险。确定合并敏感性、合并特异性和曲线下面积(AUC),以评估放射组学在预测HCC对TACE反应中的效用。

结果

在本系统评价中,有10项研究符合条件,其中6项研究用于我们的荟萃分析。RQS范围为7-21(最高可能分数:36)。合并敏感性和特异性分别为0.89(95%置信区间(CI)=0.79-0.95)和0.82(95%CI=0.64-0.92)。总体AUC为0.93(95%CI=0.90-0.95)。

结论

评估TACE对HCC患者疗效的放射组学相关研究显示出有前景的结果。然而,需要进行前瞻性多中心试验,以使放射组学更可行和可接受。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/090746a7b43c/fonc-13-1194200-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/90193bb16ff0/fonc-13-1194200-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/31a5908e4390/fonc-13-1194200-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/3d7efbc2da48/fonc-13-1194200-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/23d31ed72b4f/fonc-13-1194200-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/8539068789ed/fonc-13-1194200-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/090746a7b43c/fonc-13-1194200-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/90193bb16ff0/fonc-13-1194200-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/31a5908e4390/fonc-13-1194200-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/3d7efbc2da48/fonc-13-1194200-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/23d31ed72b4f/fonc-13-1194200-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/8539068789ed/fonc-13-1194200-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f22a/10374837/090746a7b43c/fonc-13-1194200-g006.jpg

相似文献

1
Radiomics features of computed tomography and magnetic resonance imaging for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis.用于预测肝细胞癌经动脉化疗栓塞反应的计算机断层扫描和磁共振成像的影像组学特征:一项荟萃分析
Front Oncol. 2023 Jul 13;13:1194200. doi: 10.3389/fonc.2023.1194200. eCollection 2023.
2
Radiomics as a tool for prognostic prediction in transarterial chemoembolization for hepatocellular carcinoma: a systematic review and meta-analysis.基于放射组学的经动脉化疗栓塞术治疗肝细胞癌的预后预测工具:系统评价和荟萃分析。
Radiol Med. 2024 Aug;129(8):1099-1117. doi: 10.1007/s11547-024-01840-9. Epub 2024 Jul 26.
3
Development of a computed tomography-based radiomics nomogram for prediction of transarterial chemoembolization refractoriness in hepatocellular carcinoma.基于计算机断层扫描的影像组学列线图用于预测肝细胞癌经动脉化疗栓塞难治性的研究进展
World J Gastroenterol. 2021 Jan 14;27(2):189-207. doi: 10.3748/wjg.v27.i2.189.
4
Radiomics Analysis Based on Contrast-Enhanced MRI for Prediction of Therapeutic Response to Transarterial Chemoembolization in Hepatocellular Carcinoma.基于对比增强磁共振成像的放射组学分析预测肝细胞癌经动脉化疗栓塞术的治疗反应
Front Oncol. 2021 Mar 31;11:582788. doi: 10.3389/fonc.2021.582788. eCollection 2021.
5
Application of Radiomics in the Efficacy Evaluation of Transarterial Chemoembolization for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.放射组学在经动脉化疗栓塞治疗肝细胞癌疗效评估中的应用:系统评价和荟萃分析。
Acad Radiol. 2024 Jan;31(1):273-285. doi: 10.1016/j.acra.2023.08.001. Epub 2023 Sep 9.
6
Diagnostic Efficacy of Contrast-Enhanced MRI in Detecting Residual or Recurrent Hepatocellular Carcinoma After Transarterial Chemoembolization: A Systematic Review and Meta-analysis.经动脉化疗栓塞术后对比增强磁共振成像检测残余或复发性肝细胞癌的诊断效能:一项系统评价和荟萃分析
J Magn Reson Imaging. 2020 Oct;52(4):1019-1028. doi: 10.1002/jmri.26970. Epub 2019 Nov 1.
7
Predicting Survival Using Pretreatment CT for Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization: Comparison of Models Using Radiomics.基于治疗前 CT 影像的影像组学模型预测接受经动脉化疗栓塞术治疗的肝细胞癌患者的生存情况。
AJR Am J Roentgenol. 2018 Nov;211(5):1026-1034. doi: 10.2214/AJR.18.19507. Epub 2018 Sep 21.
8
Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.基于术前 CT 的放射组学特征预测肝细胞癌经肝动脉化疗栓塞(TACE)治疗的反应。
Cardiovasc Intervent Radiol. 2022 Oct;45(10):1524-1533. doi: 10.1007/s00270-022-03221-z. Epub 2022 Jul 27.
9
Radiomics for Predicting Response of Neoadjuvant Chemotherapy in Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis.基于影像组学预测鼻咽癌新辅助化疗疗效的系统评价与Meta分析
Front Oncol. 2022 May 4;12:893103. doi: 10.3389/fonc.2022.893103. eCollection 2022.
10
Prediction of tumor response via a pretreatment MRI radiomics-based nomogram in HCC treated with TACE.基于 MRI 影像组学的Nomogram 模型预测 TACE 治疗 HCC 的肿瘤应答情况。
Eur Radiol. 2021 Oct;31(10):7500-7511. doi: 10.1007/s00330-021-07910-0. Epub 2021 Apr 16.

引用本文的文献

1
Diagnostic performance of microRNAs for predicting response to transarterial chemoembolization in hepatocellular carcinoma: a meta-analysis.微小RNA预测肝细胞癌经动脉化疗栓塞反应的诊断性能:一项荟萃分析。
Front Oncol. 2025 Jan 14;14:1483196. doi: 10.3389/fonc.2024.1483196. eCollection 2024.
2
Comparison of various liver cancer staging systems in predicting prognosis after initial transcatheter arterial chemoembolization: a retrospective study from China.比较不同肝癌分期系统对初次经动脉化疗栓塞术后预后的预测价值:一项来自中国的回顾性研究
J Gastrointest Oncol. 2024 Dec 31;15(6):2599-2612. doi: 10.21037/jgo-2024-850. Epub 2024 Dec 27.
3

本文引用的文献

1
Application of Radiomics in Predicting Treatment Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer: Strategies and Challenges.放射组学在预测局部晚期直肠癌新辅助放化疗治疗反应中的应用:策略与挑战
J Oncol. 2022 Nov 26;2022:1590620. doi: 10.1155/2022/1590620. eCollection 2022.
2
Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy.人工智能与放射组学:免疫治疗中的基础、应用及挑战。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-005292.
3
Diagnostic performance of radiomics in adrenal masses: A systematic review and meta-analysis.
Contributing to the prediction of prognosis for treated hepatocellular carcinoma: Imaging aspects that sculpt the future.
有助于预测经治疗肝细胞癌的预后:塑造未来的影像学方面。
World J Gastrointest Surg. 2024 Oct 27;16(10):3377-3380. doi: 10.4240/wjgs.v16.i10.3377.
4
Can Patient Characteristics and Pre-Treatment MRI Features Predict Survival After Stereotactic Ablative Radiotherapy (SABR) Treatment in Hepatocellular Carcinoma (HCC): Preliminary Assessment.能否通过患者特征和治疗前 MRI 特征预测肝癌(HCC)立体定向消融放疗(SABR)治疗后的生存情况:初步评估。
Curr Oncol. 2024 Oct 19;31(10):6384-6394. doi: 10.3390/curroncol31100474.
5
Applications of artificial intelligence in interventional oncology: An up-to-date review of the literature.人工智能在介入肿瘤学中的应用:文献综述
Jpn J Radiol. 2025 Feb;43(2):164-176. doi: 10.1007/s11604-024-01668-3. Epub 2024 Oct 2.
肾上腺肿块中影像组学的诊断性能:一项系统评价和荟萃分析。
Front Oncol. 2022 Sep 2;12:975183. doi: 10.3389/fonc.2022.975183. eCollection 2022.
4
Hepatocellular carcinoma.肝细胞癌
Lancet. 2022 Oct 15;400(10360):1345-1362. doi: 10.1016/S0140-6736(22)01200-4. Epub 2022 Sep 6.
5
Preoperative CECT-based Radiomic Signature for Predicting the Response of Transarterial Chemoembolization (TACE) Therapy in Hepatocellular Carcinoma.基于术前 CT 的放射组学特征预测肝细胞癌经肝动脉化疗栓塞(TACE)治疗的反应。
Cardiovasc Intervent Radiol. 2022 Oct;45(10):1524-1533. doi: 10.1007/s00270-022-03221-z. Epub 2022 Jul 27.
6
Radiomics Analysis on Gadoxetate Disodium-Enhanced MRI Predicts Response to Transarterial Embolization in Patients with HCC.钆塞酸二钠增强MRI的影像组学分析预测肝癌患者经动脉栓塞治疗的反应
Diagnostics (Basel). 2022 May 24;12(6):1308. doi: 10.3390/diagnostics12061308.
7
Tumor and peritumor radiomics analysis based on contrast-enhanced CT for predicting early and late recurrence of hepatocellular carcinoma after liver resection.基于增强 CT 的肿瘤和瘤周放射组学分析预测肝癌切除术后早期和晚期复发。
BMC Cancer. 2022 Jun 17;22(1):664. doi: 10.1186/s12885-022-09743-6.
8
Preoperative Prediction of Microvascular Invasion Risk Grades in Hepatocellular Carcinoma Based on Tumor and Peritumor Dual-Region Radiomics Signatures.基于肿瘤和瘤周双区域影像组学特征的肝细胞癌微血管侵犯风险等级术前预测
Front Oncol. 2022 Mar 22;12:853336. doi: 10.3389/fonc.2022.853336. eCollection 2022.
9
18F-FDG PET Radiomics as Predictor of Treatment Response in Oesophageal Cancer: A Systematic Review and Meta-Analysis.18F-FDG PET 影像组学作为食管癌治疗反应的预测指标:一项系统评价与Meta分析
Front Oncol. 2022 Mar 15;12:861638. doi: 10.3389/fonc.2022.861638. eCollection 2022.
10
Radiomics models for preoperative prediction of microvascular invasion in hepatocellular carcinoma: a systematic review and meta-analysis.用于术前预测肝细胞癌微血管侵犯的影像组学模型:一项系统评价与荟萃分析
Abdom Radiol (NY). 2022 Jun;47(6):2071-2088. doi: 10.1007/s00261-022-03496-3. Epub 2022 Apr 1.